Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Avelumab in Treating Patients with Advanced or Metastatic Small Intestine Cancer

This pilot phase II trial studies the side effects of avelumab and how well it works in treating patients with small intestine cancer that has spread to other places in the body or usually cannot be cured or controlled with treatment. Monoclonal antibodies, such as avelumab, may interfere with the ability of tumor cells to grow and spread.
Not Available
Cardin, Dana

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: